OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Pavel Petukhov

1 Projects | 1 Researchers | $142,100 Invested

2010

University of Illinois at Chicago

Pavel Petukhov, PhD

Mapping the Binding Site of HDAC 2 for the Design of Novel HDAC Inhibitors Lacking Zinc Binding Group

  • Funding Amount: $142,100
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Epigenetics
  • Status: Closed